0

Bingen Resident To Walk For 60 Miles During Three Days

All for cancer research

Brandy Miller of Bingen will join thousands of other dedicated women and men at the Seattle] Breast Cancer 3-Day benefiting Susan G. Komen for the Cure and National Philanthropic Trust.

After months of training and fundraising, participants will walk 60 miles during three days to raise awareness and funds for critical research and community outreach programs.

"As a Breast Cancer 3-Day participant, I have an opportunity to celebrate breast cancer survivorship, honor those who lost their lives to the disease, and ultimately, have an enormous impact on awareness and funding for breast cancer research and community outreach programs," said Miller. "The Breast Cancer 3-Day is challenging and fun and the memory of my personal accomplishment will last a lifetime."

The Seattle Breast Cancer 3-Day will start on Friday morning, Sept. 12, and end with the closing ceremony on Sunday afternoon, Sept. 14. The walkers will cover about 20 miles a day, traveling at their own pace. The walkers will be supported by hundreds of volunteer crew members who will provide meals, liquid and snack stops, gear transport, hot showers, portable restrooms, safety on the streets and 24-hour medical services.

The actual journey starts months in advance when walkers start training and raising the $2,200 required fundraising minimum. To help prepare for the Breast Cancer 3-Day, each walker is supported by coaches and online assistance that aid in all aspects of training and fundraising, while clinics, meetings, and training walks provide ongoing support.

To help Miller reach her goal, make a donation directly to her online donation page or join her team at http://08.the3day.org/goto/mommagrams.

There will also be a Help Strike out Breast Cancer Bowling Fundraiser June 14 from 2 to 5 p.m. at Orchard Lanes in Hood River. The cost is $3.00 per game including shoes and all the proceeds go towards the team's goal to help find a cure for Breast Cancer.

Comments

Use the comment form below to begin a discussion about this content.

Sign in to comment